Ketcher 11302114052D 1 1.00000 0.00000 0 26 29 0 0 0 999 V2000 16.8678 -13.7876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 16.5543 -14.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.3680 -15.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.1750 -14.7345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.8681 -13.7876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 17.3680 -16.3220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.2284 -16.8222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.1823 -16.5087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.7691 -17.3223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.1823 -18.1293 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 18.2284 -17.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.3680 -18.3230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 16.5008 -17.8226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.5008 -16.8222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.8998 -12.6003 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 14.8870 -12.7538 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 15.6940 -12.1669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.2739 -12.9806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.4739 -13.5675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.0878 -12.3935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.9812 -11.3931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.8745 -10.3991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.2724 -13.3794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2839 -13.2258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.1205 -11.9729 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 14.0535 -11.6118 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 2 3 2 0 0 0 3 4 1 0 0 0 4 5 2 0 0 0 5 1 1 0 0 0 3 6 1 0 0 0 6 7 2 0 0 0 7 8 1 0 0 0 8 9 2 0 0 0 9 10 1 0 0 0 10 11 1 0 0 0 11 7 1 0 0 0 11 12 2 0 0 0 12 13 1 0 0 0 13 14 2 0 0 0 14 6 1 0 0 0 15 16 1 0 0 0 16 17 1 0 0 0 17 18 1 0 0 0 18 19 1 0 0 0 19 16 1 0 0 0 18 20 1 0 0 0 20 21 1 0 0 0 21 22 3 0 0 0 18 1 1 0 0 0 15 23 1 0 0 0 23 24 1 0 0 0 15 25 2 0 0 0 15 26 2 0 0 0 M END > CHEBI:95341 > baricitinib > A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine substituted by a 1-[3-(cyanomethyl)-1-(ethanesulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl group at position 5. It is an FDA approved selective Janus Kinase 1 and 2 (JAK1 and JAK2) inhibitor used for the treatment of rheumatoid arthritis. > 3 > LY3009104; LY-3009104; LY 3009104; INCB028050; INCB-028050; INCB 028050; 2-(3-(4-(3H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile > {1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile > baricitinibum; baricitinib; baricitinib; baricitinib > Olumiant > C16H17N7O2S > 371.420 > 371.11644 > 0 > CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1 > InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) > XUZMWHLSFXCVMG-UHFFFAOYSA-N > 1187594-09-7 > 1187594-09-7 > DB11817 > D10308 > LSM-6709 > 3JW > Baricitinib > PMC8606629 > 26853940; 27910962; 30036348; 30871014; 30907116; 32856090; 33451175; 33456084; 33502499; 33870531; 33961266; 34110416; 34195587; 34237007; 34247230; 34250455; 34321249; 34358107; 34379541; 34393789; 34424311; 34468689; 34501467; 34553429; 34647989; 34747511; 34785883 $$$$